An open-label single-arm phase II study of regorafenib for the treatment of angiosarcoma

Mark Agulnik, Brian Schulte, Steven Robinson, Angela C. Hirbe, Kevin Kozak, Sant P. Chawla, Steven Attia, Alfred Rademaker, Hui Zhang, Susan Abbinanti, Rasima Cehic, Varun Monga, Mohammed Milhem, Scott Okuno, Brian A. Van Tine

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)201-208
Number of pages8
JournalEuropean Journal of Cancer
Volume154
DOIs
StatePublished - Sep 2021

Keywords

  • Angiosarcoma
  • Phase 2
  • Regorafenib
  • Sarcoma
  • TKI

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'An open-label single-arm phase II study of regorafenib for the treatment of angiosarcoma'. Together they form a unique fingerprint.

Cite this